Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamila A Marzec

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biomed Research International|July 30, 2015
Targeting Insulin-Like Growth Factor Binding Protein-3 Signaling in Triple-Negative Breast CancerKamila A Marzec, Robert C Baxter, Janet L Martin
Cancer Letters|August 2, 2016
BARD1 splice variants display mislocalization in breast cancer cells and can alter the apoptotic response to cisplatinKamila A Marzec, Estefania Martino-Echarri, Irmgard Irminger-Finger, et al.
Oncotarget|September 18, 2015
Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damageKamila A Marzec, Mike Z Lin, Janet L Martin, et al.
Cell|October 19, 2019
SnapShot: S-Phase Entry and ExitAndrew Burgess, Jenny Vuong, Kamila A Marzec, et al.
Scientific Reports|June 22, 2022
SILAC kinase screen identifies potential MASTL substratesKamila A Marzec, Samuel Rogers, Rachael McCloy, et al.
Cancers|August 23, 2020
YB-1 Knockdown Inhibits the Proliferation of Mesothelioma Cells through Multiple MechanismsThomas G Johnson, Karin Schelch, Kaitao Lai, et al.
Genes & Diseases|March 22, 2024
<i>C. elegans</i> model of riboflavin transporter deficiency (RTD) disorder reveals deficits in synaptic transmission and movementRamesh K Narayanan, Gonzalo Perez-Siles, Kamila A Marzec, et al.
Cellular Signalling|May 30, 2015
The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic functionVarsha Tembe, Estefania Martino-Echarri, Kamila A Marzec, et al.
Elife|May 13, 2021
A non-genetic, cell cycle-dependent mechanism of platinum resistance in lung adenocarcinomaAlvaro Gonzalez Rajal, Kamila A Marzec, Rachael A McCloy, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biomed Research International|July 30, 2015
Targeting Insulin-Like Growth Factor Binding Protein-3 Signaling in Triple-Negative Breast CancerKamila A Marzec, Robert C Baxter, Janet L Martin
Cancer Letters|August 2, 2016
BARD1 splice variants display mislocalization in breast cancer cells and can alter the apoptotic response to cisplatinKamila A Marzec, Estefania Martino-Echarri, Irmgard Irminger-Finger, et al.
Oncotarget|September 18, 2015
Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damageKamila A Marzec, Mike Z Lin, Janet L Martin, et al.
Cell|October 19, 2019
SnapShot: S-Phase Entry and ExitAndrew Burgess, Jenny Vuong, Kamila A Marzec, et al.
Scientific Reports|June 22, 2022
SILAC kinase screen identifies potential MASTL substratesKamila A Marzec, Samuel Rogers, Rachael McCloy, et al.
Cancers|August 23, 2020
YB-1 Knockdown Inhibits the Proliferation of Mesothelioma Cells through Multiple MechanismsThomas G Johnson, Karin Schelch, Kaitao Lai, et al.
Genes & Diseases|March 22, 2024
<i>C. elegans</i> model of riboflavin transporter deficiency (RTD) disorder reveals deficits in synaptic transmission and movementRamesh K Narayanan, Gonzalo Perez-Siles, Kamila A Marzec, et al.
Cellular Signalling|May 30, 2015
The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic functionVarsha Tembe, Estefania Martino-Echarri, Kamila A Marzec, et al.
Elife|May 13, 2021
A non-genetic, cell cycle-dependent mechanism of platinum resistance in lung adenocarcinomaAlvaro Gonzalez Rajal, Kamila A Marzec, Rachael A McCloy, et al.
Pageof 1